Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation.: International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation

被引:100
作者
Ansell, J
Jacobson, A
Levy, J
Völler, H
Hasenkam, JM [1 ]
机构
[1] Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, DK-8200 Aarhus, Denmark
[2] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[3] Loma Linda Univ, Loma Linda, CA 92357 USA
[4] Loma Linda VA, VAMC 111C, Associate Chief Staff Res, Loma Linda, CA 92357 USA
[5] Gen Practitioner Specialist Patient Self Monitori, London, England
[6] Klin See, Rehabil Ctr Cardiovasc Dis, D-15562 Rudersdorf, Germany
关键词
patient self-management; oral anticoagulant therapy; international normalised ratio; coagulometer; international consensus guidelines;
D O I
10.1016/j.ijcard.2003.11.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: This document provides health care professionals involved in initiating and monitoring oral anticoagulation therapy with guidelines for the provision of safe and effective patient self-testing/patient self-management of oral anticoagulation. Methods and results: The consensus group has critically reviewed the literature and compared the results of usual care (UC) vs. anticoagulation clinic and patient self-management/patient self-testing (PSM/PST). The education and training of patients for self-monitoring are described, together with the suitability of patients, the effect on quality of life and cost-effectiveness. The consensus agrees that patient self-testing and patient self-management are effective methods of monitoring oral anticoagulation therapy, providing outcomes at least as good as, and possibly better than, those achieved with an anticoagulation clinic. All patients must be appropriately selected and trained. Currently available self-testing/self-management devices give INR results which are comparable with those obtained in laboratory testing. The most frequent testing frequency is weekly but lower frequency of testing can be justified based on institutional or patient conditions. Conclusions: The consensus agrees that there are several points in favour of PST/PSM, for example, a higher degree of medical safety, increased patient education, improved response to changes in lifestyle, increased independence for the patient and improved quality of life. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 60 条
  • [51] THE EFFECT OF WARFARIN ON MORTALITY AND REINFARCTION AFTER MYOCARDIAL-INFARCTION
    SMITH, P
    ARNESEN, H
    HOLME, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (03) : 147 - 152
  • [52] Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort
    Steffensen, FH
    Kristensen, K
    Ejlersen, E
    Dahlerup, JF
    Sorensen, HT
    [J]. JOURNAL OF INTERNAL MEDICINE, 1997, 242 (06) : 497 - 503
  • [53] Cost-effectiveness of self-managed anticoagulant therapy in Germany
    Taborski, U
    Wittstamm, FJ
    Bernardo, A
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (01) : 103 - 107
  • [54] Tripodi A, 1997, THROMB HAEMOSTASIS, V78, P855
  • [55] van den Besselar AMHP, 2000, THROMB HAEMOSTASIS, V84, P410
  • [56] BLEEDING COMPLICATIONS IN ORAL ANTICOAGULANT-THERAPY - AN ANALYSIS OF RISK-FACTORS
    VANDERMEER, FJM
    ROSENDAAL, FR
    VANDENBROUCKE, JP
    BRIET, E
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (13) : 1557 - 1562
  • [57] VOLLER H, 1998, ANN HEMATOL S1, V76, pA99
  • [58] Watzke HH, 2000, THROMB HAEMOSTASIS, V83, P661
  • [59] HOME PROTHROMBIN TIME MONITORING AFTER THE INITIATION OF WARFARIN THERAPY - A RANDOMIZED, PROSPECTIVE-STUDY
    WHITE, RH
    MCCURDY, SA
    VONMARENSDORFF, H
    WOODRUFF, DE
    LEFTGOFF, L
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 111 (09) : 730 - 737
  • [60] WILT VM, 1995, PHARMACOTHERAPY, V15, P732